<bill session="118" type="h" number="5708" updated="2024-07-24T15:20:18Z">
  <state datetime="2023-09-26">REFERRED</state>
  <status>
    <introduced datetime="2023-09-26"/>
  </status>
  <introduced datetime="2023-09-26"/>
  <titles>
    <title type="display">MCM PRV Reauthorization Act</title>
    <title type="short" as="introduced">MCM PRV Reauthorization Act</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to extend a priority review program to encourage treatments for agents that present national security threats.</title>
  </titles>
  <sponsor bioguide_id="F000475"/>
  <cosponsors>
    <cosponsor bioguide_id="P000616" joined="2023-09-26"/>
  </cosponsors>
  <actions>
    <action datetime="2023-09-26">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-09-26" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2023-09-29">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Chemical and biological weapons"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments/>
</bill>
